Poster Session 2-20 PTCL: Clinical

Sat. Oct 12, 2019 5:10 PM - 5:40 PM Poster (Tokyo International Forum, B2F Hall E)

Chair: Kyoko Inokura (Department of Hematology, Sendai City Hospital)

+Add all to schedule

[PS2-20-1] Post-treatment level of soluble interleukin-2 receptor predicts subsequent relapse in PTCL

Wataru Kishimoto, Noriyoshi Yoshinaga, Chiyoko Ueda, Tsuneyoshi Hamada, Shoichi Doi, Toshinori Moriguchi (Dep. Hematol., Kyoto-Katsura Hosp., Kyoto, Japan)

[PS2-20-2] Event-free survival at 24 months is a prognostic predictor for peripheral T-cell lymphoma in Japan

Joji Shimono¹, Takashi Ishio¹, Hideki Goto¹, Akio Shigematsu², Shuichi Ota², Hajime Kobayashi³, Yutaka Tsutsumi⁴, Satoshi Yamamoto⁵, Yasutaka Kakinoki⁶, Mitsutoshi Kurosawa⁷, Takeshi Kondo⁸, Hiroshi Iwasaki⁹, Hajime Sakai¹⁰, Takuto Miyagishima¹¹, Yoshihito Haseyama¹², Yasuyuki Kunieda¹³, Takahiro Nagashima¹⁴, Mitsufumi Nishio¹⁵, Satoshi Hashino¹⁶, Yoshihiro Matsuno¹⁷, Masao Nakagawa¹, Takanori Teshima¹ (1.Hokkaido University, Hematology, Sapporo, Japan, 2.Sapporo Hokuyu Hospital, Hematology, Sapporo, Japan, 3.Obihiro Kosei Hospital, Hematology, Obihiro, Japan, 4.Hakodate City Hospital, Hematology, Hakodate, Japan, 5.Sapporo City Hospital, Hematology, Sapporo, Japan, 6.Asahikawa City Hospital, Hematology, Asahikawa, Japan, 7.Hokkaido Cancer Center, Hematology, Sapporo, Japan, 8.Aiiku Hospital, Hematology, Sapporo, Jaoan, 9.Sapporo Kosei Hospital, Hematology, Sapporo, Japan, 10.Teine Keijinkai Hospital, Hematology, Sapporo, Japan, 11.Kushiro Rosai Hospital, Hematology, Kushiro, Japan, 12.Tonan Hospital, Hematology, Sapporo, Japan, 13.Wakkanai City Hospital, Intern Medcine, Wakkanai, Japan, 14.Kitami Red Cross Hosptial, Hematology, Kitami, Japan, 15.NTT East Sapporo Hospital, Hematology, Sapporo, Japan, 16.Hokkaido University, Health Care Center, Sapporo, Japan, 17.Hokkaido University, Pathology, Sapporo, Japan)

[PS2-20-3] Analysis of clinical characteristic and outcome of T cell lymphomas in single institution

Yoshiko Inoue, Mitsunori Ueno, Taichi Hirano, Norikazu Mitsui, Toshiro Kawakita, Tatsunori Sakai, Naoko Harada, Michihiro Hidaka (National Hospital Organaization Kumamoto Medical Center, Kumamoto Japan)

[PS2-20-4] Case reports of refractory PTCL used romidepsin and review of survival outcome in our hospital

Takanori Toyama (Internal Medicine, Miyazaki Prefectual Nobeoka Hopspital, Nobeoka, Japan)

[PS2-20-5] Successful treatment of low-dose romidepsin for refractory PTCL-NOS after CHOP and two novel agents

Keita Nakayama¹, Shuhei Kanaya^1,3, Ikuko Matsumura¹, Akio Saito¹, Takatomo Yoshida², Kohtaro Toyama¹ (1.Department of Hematology., Fujioka General Hospital., Gunma, Japan, 2.Department of Pathology., Fujioka General Hospital., Gunma, Japan, 3.Department of Hematology., Saiseikai Maebashi Hospital., Gunma, Japan)

[PS2-20-6] Spontaneous regression of methotrexate-associated T-cell lymphoproliferative disorders

Makoto Oyama¹, Junichi Kiyasu^1,2, Fumiko Arakawa², Yu Yagi¹, Takamitsu Matsushima¹, Koichi Ohshima², Yuji Yufu¹ (1.Department of Hematology, Iizuka Hospital, Fukuoka, Japan, 2.Department of Pathology, Kurume University, Kurume, Japan)